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1. Introduction  
Urban atmospheric air pollution is considered a significant challenge for environmental 
Health (Brunekreef & Holgate, 2002; World Health Organization [WHO], 2003). Growing 
epidemiological evidence has supported the association between air pollution and 
cardiovascular morbidity and mortality (Brook et al., 2010). The biological mechanisms 
underlying these associations remain obscure (Kaufman 2010). One possible explanation to 
this association is that air pollution has been shown to cause pulmonary inflammation 
which is further associated with the production of local inflammatory mediators 
(Nurkiewicz et al., 2008; Nurkiewicz et al., 2009; Kido et al., 2011). These mediators in turn 
enter the systemic circulation and could contribute to the acceleration of atherothrombotic 
disease (Seaton et al., 1999; Ghio et al., 2000; Peters et al., 2001b; van Eeden & Hogg, 2002; 
Pope et al., 2004). Animal models of accelerated atherosclerosis following exposure to air 
pollution, strongly support this potential mechanism (Sun et al., 2005; Niwa et al., 2008). 
Low grade systemic inflammation has repeatedly been shown to be a contributing factor in 
the etiopathogenesis of atherothrombotic disease (Libby 2002; Danesh et al., 2005; Libby, 
2006). A hint to the link between air pollution and systemic inflammation arises from 
studies demonstrating some type of correlation between inflammatory biomarkers, and the 
amount of outdoor atmospheric particles and volatile gases (Schwartz, 2001; Ghio et al., 
2003; Liao et al., 2005; Diez Roux et al., 2006; Steinvil et al., 2008). 
Exposure to combustion-derived air pollution is associated as well to an early (1-2 h) and 
sustained (24 h) rise in cardiovascular morbidity and mortality (Peters et al., 2001a; Peters et 
al., 2004). Toxicological diesel exposure studies have demonstrated a selective and persistent 
impairment of endothelium-dependent vasodilatation that occurs in the presence of mild 
systemic inflammation (Mills et al., 2007; Tornqvist et al., 2007), coronary vasoconstriction 
(Cherng et al., 2009), as well as an increase in ex-vivo thrombus formation and in- vivo 
platelet activation (Lucking et al., 2008). Less attention has however been given to 
measuring pollutants and exposures near heavily-trafficked highways. The most widely 
reported pollutants in vehicular exhaust include carbon monoxide, nitrogen and sulfur 
oxides, unburned hydrocarbons (from fuel and crankcase oil), particulate matter, polycyclic 
aromatic hydrocarbons, and other organic compounds that derive from combustion (Brugge 
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et al., 2007). While several recent studies have shown that sharp pollutant gradients exist 
near highways, most reports did not however examine this effect on the inflammatory 
response in over 400 meters (Brugge et al., 2007).  
2. Methods  
In the present analysis we have investigated the relationship between commonly measured 
combustion derived air pollutants and inflammatory biomarkers in apparently healthy 
individuals residing at a 1000 meter radius from a traffic air pollution monitoring station. 
2.1 Population  
In the present study we analyzed the data collected as part of the Tel-Aviv Medical Center 
Inflammation Survey (TAMCIS), a registered data bank of the Israeli Ministry of Justice 
(Rogowski et al., 2006). This is a relatively large survey comprising of apparently healthy 
individuals attending a center for periodic health examinations. In our study, patients 
attending the Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel for a routine health 
examination between September 2002 and August 2010 were invited to participate in the 
TAMCIS. All individuals enrolled were recruited during their routine annual health check-
up and gave their written consent in accordance with the guidelines of the Institutional 
Ethics Committee. A total of 15,605 subjects gave their informed consent (9,881 males, 5,724 
females). 2,773 subjects were later excluded from the analysis due to known inflammatory 
disease (arthritis, inflammatory bowel disease, psoriasis, etc.), pregnancy, steroidal or 
nonsteroidal treatment (except for aspirin at a dose of  325 mg/dl), acute infection or 
invasive procedures (surgery, catheterization, etc.) during the last 6 months. An additional 
12,387 subjects were further excluded for living more than 1000 meter away from the nearest 
traffic-related air pollution monitoring station. Following these exclusions the study group 
comprised of 445 individuals (262 males and 183 females). All distance calculations between 
the traffic-related air pollution monitoring stations and the specific household addresses of 
all TAMCIS participants were performed by the Survey of Israel, a national authority for 
mapping, cadastre, geodesy and geoinformation.  
2.2 Laboratory methods  
As part of the survey, we employed a set of analyzes to assess the levels of the inflammation 
sensitive biomarkers of the acute phase: Fibrinogen was quantified by the method of Clauss 
(Clauss, 1957) and a Sysmex 6000 (Sysmex Corporation, Hyaga, Japan) autoanalyzer while 
the high sensitivity C-reactive protein (hs-CRP) was measured using a Behring BN II 
Nephelometer (DADE Behring, Marburg, Germany) (Rifai et al., 1999). The erythrocyte 
sedimentation rate (ESR) was determined by using the method of Westergren(International 
Council for Standardization in Haematology [ICSH], 1993).  
2.3 Definition of atherothrombotic risk factors  
Results of the routine health check-up were assessed employing certain definitions in order 
to recognize atherothrombotic risk factors in individuals. These included diabetes mellitus 
which was defined as a fasting blood glucose concentration of ≥ 126 mg/dl (7.0 mmol/L) or 
the intake of insulin or oral hypoglycemic medications. Hypertension was defined as a 
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blood pressure of >140/90 mm Hg on two separate measurements or the use of 
antihypertensive medications.  Dyslipidemia was defined as the low density lipoprotein 
cholesterol (LDL-C) or non-high density lipoprotein cholesterol (non-HDL-C) 
concentrations, for individuals displaying elevated triglyceride concentrations of 
> 200 mg/dl (2.26 mmol/L), above the recommended levels according to the risk profile 
defined by the updated adult treatment panel III (ATP III) recommendations or the use of 
lipid lowering medications(National Cholesterol Education Program/Adult Treatment 
Panel III [NCEP/ATPIII], 2001). The diagnosis of the metabolic syndrome was based on the 
joint interim statement of the International Diabetes Federation Task Force on Epidemiology 
and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; 
World Heart Federation; International Atherosclerosis Society; and International Association 
for the Study of Obesity (Alberti et al., 2009). In short, Elevated waist circumference was 
defined as ≥94 cm (37 inches) in men and ≥80 (31.5 inches) in women as recommended for 
europid and middle east; Elevated triglycerides (TG) were defined as ≥150 mg/dl (1.7 
mmol/l) or on drug treatment for elevated triglycerides; Reduced HDL-C was defined as 
<40 mg/dL (1.0 mmol/l) in men and <50 mg/dl (1.3 mmol/l) in women or on drug 
treatment for reduced HDL-C; Elevated blood pressure was defined as ≥130 mm Hg systolic 
blood pressure or ≥85 mm Hg diastolic blood pressure or on antihypertensive drug 
treatment in a patient with a history of hypertension; Elevated fasting glucose was defined 
as ≥100 mg/dl (5.55 mmol/l).  Smokers were defined as individuals who smoked at least 5 
cigarettes per day while past smokers had quit smoking for at least 30 days prior to 
examination. 
2.4 Air pollution and weather data  
Air pollution and weather data were downloaded online from the Israeli Ministry of 
Environmental Protection web page. Major air pollutants and the weather data are routinely 
measured every half hour by the same traffic-related air pollution monitoring stations, 
which are adjacent to specific heavy traffic sites. The Israeli Ministry of Environmental 
Protection has deployed seven of such stations thorough out Israel. These stations routinely 
measure several major pollutants including nitrogen oxides (NO, NO2, NOx) and carbon 
monoxide (CO). Since only one traffic-related air monitoring station measured PM10 
(particles less than 10 microns in aerodynamic diameter) and sulfur dioxide (SO2) the 
number of individuals included in a 1 km radius was too small for statistical power. Thus 
we have only analyzed the effect of the former pollutants on the inflammatory variables. 
The analytical monitors in each station are fully automated and U.S. Environmental 
Protection Agency (EPA) approved. They also include a daily automated calibration system. 
Once a year, the stations conduct quality control and quality assurance tests.  Nitrogen 
dioxide was measured by Chemiluminescence NO-NO2-NOx analyzer (Thermo 
Environmental Instruments Inc. USA, Model 42C) and Carbon monoxide by Gas Filter 
Correlation (GFC) CO Analyzer (Thermo Environmental Instruments Inc. USA, Model 48C).  
2.5 Statistical analysis  
All data was summarized and displayed as mean, standard deviation (SD), and quartiles for 
the continuous variables and as number of patients plus the percentage in each group for 
categorical variables. Since High Sensitivity C-Reactive Protein (hs-CRP), ESR and the 
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triglyceride concentrations displayed irregular distributions, we used a logarithmic 
transformation which converted the distributions to normal ones for all statistical 
procedures. Therefore all results of hs-CRP, ESR or triglyceride concentrations are expressed 
as back transformed geometrical mean and standard deviation. The One-Way Kolmogorov-
Smirnov test was used to assess the distributions. 
In contrast to many other studies that evaluated air pollution, we did not divide the 
different air pollutants into tiles or commonly used cut-off points, rather we treated them as 
continuous variables. In order to quantify the contribution of each air pollutant to the 
variability of the different inflammation sensitive biomarkers we performed linear 
regression models using the forward stepwise method, where the inflammatory biomarkers 
were regarded as the dependent variable and many possible and known confounding 
parameters in addition to the air pollution as the independent variables.  These confounders 
include parameters with known or suspected influences on inflammatory sensitive 
biomarkers and in addition to each air pollution, included gender, age, waist circumference, 
BMI, complete lipid profile including low-density lipoprotein (LDL), high-density 
lipoprotein (HDL), and triglycerides, diastolic and systolic blood pressure measurements, 
glucose concentration, alcohol consumption, sport intensity, medications including aspirin, 
beta blockers, calcium channel blockers, angiotensin converting enzyme inhibitors, 
angiotensin II receptor blockers, statins, fibrates and oral contraceptives or hormonal 
replacement therapy for women, cardiovascular risk factors including diabetes mellitus, 
current and past smoking status and family history of coronary heart disease or personal 
history of proven atherothrombotic event (myocardial infarction, cerebrovascular event or 
peripheral artery disease).  
In addition, in order to control for seasonal variation and for the differences in climate 
between the years the models included the same day’s climate parameters (temperature and 
relative humidity), the season and the year of measurement. Single pollutant linear 
regression models were fitted for the inflammatory variables and air pollution parameters 
with the appropriate meteorological parameters with various lag days ranging from the day 
of blood withdrawal to as much as three days lag. In all linear regression models we tested 
the distribution of the residuals for normality. The results of the linear regression models are 
presented as the mean change plus the 95% confidence interval for one standard deviation 
(SD) increase in the air pollutant. According to the logarithmic transformation of hs-CRP 
and ESR, the expected change in the linear model for hs-CRP and ESR reflects relative 
change and is presented as percent of change, rather than absolute change. All above 
analyses were considered significant at p<0.05 (two tailed). The SPSS statistical package was 
used to perform all statistical evaluation (SSPS Inc., Chicago, IL, USA). 
3. Results  
We have presently analyzed a total of 445 individuals (262 males and 183 females) at the 
respective mean (SD) age of 44 (13). The characteristic age, BMI, blood pressure, lipid profile 
as well as alcohol consumption and sport intensity are presented in Table 1, while the 
respective percentage of individuals with different cardiovascular risk factors and relevant 
medications in Table 2. Table 3 presents the distribution of the different air pollutants and 
weather parameters collected. 
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Age (years) 45 13 34 45 55 
Waist (cm) 88 13 79 89 97 
BMI (kg/m2) 26 4 23 25 28 
Systolic BP (mmHg) 121 17 110 120 130 
Diastolic BP (mmHg) 76 9 70 75 80 
Glucose (mg/dL) 93 17 84 90 97 
HDL Cholesterol (mg/dL) 58 17 46 55 68 
LDL Cholesterol (mg/dL) 119 32 95 117 139 
Triglycerides (mg/dL) 103 2 70 105 143 
Alcohol consumption (glass/week) 1.4 2.9 0 0 2 
Sport intensity (hours/week) 2.3 3.1 0 2 3.5 
hsCRP (mg/L) 1.4 3.0 0.7 1.3 2.9 
Fibrinogen (mg/dL) 292 59 246 289 330 
ESR (mm/hr) 10 2 6 12 19 
BMI – Body Mass Index; HDL – High Density Lipoprotein; LDL – Low Density Lipoprotein; hsCRP – 
High-Sensitivity C-Reactive Protein. 
Table 1. Baseline topometric and laboratory data of the study population. 
 
 
 N % 
Current smoker 98 22.0 
Past Smoker 96 21.6 
Diabetes Mellitus 21 4.7 
Hypertension 97 21.8 
Dyslipidemia 124 27.9 
Family History of CHD 68 15.3 
Aspirin 35 7.9 
Beta blockers 29 6.5 
Calcium channel blockers 12 2.7 
ACE Inhibitors / ARB's 17 3.8 
Statins 48 10.8 
Fibrates 5 1.1 
Oral hypoglycemics 11 2.5 
Insulin 2 0.4 
ACE – Angiotensin Converting Enzyme; ARB – Angiotensin II Receptor Blocker; CHD – Coronary 
Heart Disease. 
Table 2. Baseline characteristics and medications use of the study population. 
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Temperature (˚C) 21.1 5.3 16.6 20.9 26.6 
Relative Humidity (%) 65.4 10.0 59.9 67.1 72.5 
NO2 (PPB) 29.9 9.3 23.0 27.7 35.4 
NO (PPB) 50.6 41.6 21.3 38.6 64.8 
NOX (PPB) 63.2 47.4 32.2 46.8 81.9 
CO (PPM) 0.8 0.4 0.6 0.8 1.0 
PPB – Parts Per Billion; PPM – Parts Per Million. 
Table 3. Air pollution and meteorology parameters 
We systematically evaluated the contribution of each air pollution parameter to the 
variability of the inflammatory biomarker following adjustment for weather conditions at 
the same day, seasonal influence and many known and possible contributors. The results 
are displayed in Table 4 through 6 for hs-CRP, fibrinogen and ESR. It is evident that, in our 
study group, a statistically significant increase was noted in hs-CRP following exposure to 
NO2 and NO at the day of measurement alone. This affect was only marginally significant 
with regard to CO and NOx. Fibrinogen however, showed a statistically significant decrease 
following same day exposure to NO and CO as well as following exposure of a 3 day lag.  
The ESR however, was not significantly affected by any air pollutant in our study.  
 
  Partial 
correlation 
Relative (95% CI) change (%) 
for 1 SD increase 
P Value 
NO2 Same day 0.280 38% (19% – 59%) § <0.001 
 Previous day 0.119 13% (-1% – 30%) 0.080 
 2 days ago 0.073 8% (-6% – 23%) 0.283 
 3 days ago 0.052 5% (-7% – 18%) 0.441 
NO Same day 0.193 22% (7% – 39%) § 0.004 
 Previous day 0.077 9% (-6% – 26%) 0.261 
 2 days ago 0.086 8% (-4% – 23%) 0.205 
 3 days ago 0.080 7% (-4% – 18%) 0.232 
NOX Same day 0.113 13% (-2% – 31%) 0.097 
 Previous day -0.022 -3% (-18% – 15%) 0.743 
 2 days ago -0.016 -2% (-14% – 13%) 0.814 
 3 days ago 0.030 3% (-9% – 16%) 0.655 
CO Same day 0.120 12% (-1% – 28%) 0.077 
 Previous day 0.114 12% (-2% – 29%) 0.095 
 2 days ago 0.051 4% (-7% – 17%) 0.449 
 3 days ago 0.074 6% (-5% – 18%) 0.269 
Table 4. Partial correlation and mean (95% CI) change in hs-CRP for one SD increase in each 
air pollutant 
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  Partial 
correlation 
Mean (95% CI) change (%) 
for 1 SD increase 
P Value 
NO2 Same day 0.047 3.1 (-5.8 – 12.0) 0.494 
 Previous day 0.092 5.6 (-2.6 – 13.9) 0.182 
 2 days ago 0.054 3.2 (-4.7 – 11.1) 0.054 
 3 days ago -0.087 -4.8 (-12.1 – 2.5) 0.197 
NO Same day -0.141 -8.3 (-16.1 – -0.4) 0.040 
 Previous day -0.105 -6.6 (-15.1 – 1.8) 0.127 
 2 days ago -0.074 -4.1 (-11.4 – 3.3) 0.279 
 3 days ago -0.160 -7.6 (-13.8 – -1.4) 0.018 
NOX Same day -0.006 -0.4 (-8.9 – 8.1) 0.925 
 Previous day 0.020 1.5 (-8.6 – 11.6) 0.768 
 2 days ago 0.010 0.6 (-7.4 – 8.7) 0.882 
 3 days ago -0.038 -2.1 (-9.4 – 5.3) 0.577 
CO Same day -0.151 -8.4 (-15.8 – -0.9) 0.028 
 Previous day -0.123 -7.4 (-15.4 – 0.7) 0.075 
 2 days ago -0.116 -5.8 (-12.5 – 0.9) 0.090 
 3 days ago -0.166 -8.0 (-14.4 – -1.7) 0.014 
Table 5. Partial correlation and mean (95% CI) change in fibrinogen for one SD increase in 
each air pollutant 
 
  Partial 
correlation 
Relative (95% CI) change (%) 
for 1 SD increase 
P Value 
NO2 Same day 0.085 7% (-4% - 20%) 0.231 
 Previous day 0.015 1% (-9% - 12%) 0.838 
 2 days ago -0.088 -6% (-15% - 4%) 0.215 
 3 days ago -0.032 -2% (-11% - 7%) 0.641 
NO Same day -0.049 -4% (-13% - 7%) 0.484 
 Previous day -0.091 -7% (-17% - 4%) 0.200 
 2 days ago -0.085 -6% (-14% - 4%) 0.228 
 3 days ago -0.039 -2% (-10% - 6%) 0.572 
NOX Same day 0.016 1% (-9% - 13%) 0.820 
 Previous day -0.011 -1% (-13% - 13%) 0.873 
 2 days ago -0.001 0% (-10% - 11%) 0.993 
 3 days ago 0.049 3% (-6% - 14%) 0.480 
CO Same day -0.084 -6% (-14% - 4%) 0.236 
 Previous day -0.035 -3% (-12% - 8%) 0.624 
 2 days ago -0.085 -5% (-13% - 3%) 0.230 
 3 days ago 0.008 0% (-7% - 9%) 0.911 




Advanced Topics in Environmental Health and Air Pollution Case Studies 
 
34
4. Discussion  
In the present analysis we present statistically significant associations between the short 
term exposure to traffic-related air pollutants and several inflammatory biomarkers 
including hs-CRP, and quantitative fibrinogen. The effect was documented in individuals 
residing within a 1000 meter radius of a traffic-related air pollution monitoring station, 
intentionally positioned in proximity to specific heavy traffic sites. We believe our results 
support the hypothesis of a direct influence of this short term exposure to traffic-related air 
pollutants and an eventual heightened inflammatory response that might trigger clinical 
events (Brook et al., 2010). 
Notably, we found CRP to be increased by ~40% following a one SD increase in NO2, and by 
~20% following a one SD increase in NO. Similar, albeit smaller and marginally significant 
increments, were noted for both NOx and CO, implying that an analysis in a larger sample 
size might have shown more consistent results. This rise in CRP was noted for the same day 
exposure alone, supporting the notion of its role as an acute phase reactant (Steel & 
Whitehead, 1994). In their toxicological studies in men with and without prior myocardial 
infarction, who were exposed to dilute diesel exhaust (300 μg per cubic meter) or filtered air 
for 1 hour during periods of rest and moderate exercise in a controlled-exposure facility, 
both Mills and Tornqvist did not show increments in serum C-reactive protein 
concentrations 6 or 24 hours by exposure to diesel exhaust or filtered air (Mills et al., 2007; 
Tornqvist et al., 2007). Lucking et al (Lucking et al., 2008) has shown similar results when 
reporting his toxicological study in which no changes in plasma TNF-a, IL-6, C-reactive 
protein, and soluble ICAM-1 concentrations were observed. These measurements were 
obtained however, only 6 hours following both diesel exhaust and filtered air exposures. 
Tornqvist et al, did in fact show a 24 hour significant rise in IL-6 following diesel exhaust 
exposure (Tornqvist et al., 2007). IL-6 is widely known as a direct inducer of CRP production 
in the liver hepatocytes (Steel & Whitehead 1994). Thus, our environmental real-life 1000 
meter radius traffic-related exposure findings can be supported by his toxicological findings.  
Interestingly, following exposure to CO and NO, fibrinogen concentrations decreased both 
in same day as well in 3 days following exposure. Previous environmental air pollution 
epidemiological studies have shown conflicting trends. Although some have demonstrated 
increased levels of fibrinogen, other studies measuring the same factors have failed to show 
any association with particulate exposure. Schwartz et al (Schwartz, 2001) found a 
significant negative association between the previous day fibrinogen concentration and 
NO2, as did Seaton et al (Seaton et al., 1999) for the previous three days average of PM10.  In 
contrast, Pekkanen et al. (Pekkanen et al., 2000) reported a positive significant correlation 
between fibrinogen concentration and NO2 or CO in London, with three days lag. In a large 
epidemiological study we have previously reported that mainly NO2, SO2 and CO affected 
fibrinogen in several lag days, with maximal effect for a lag of four days (Steinvil et al., 
2008). Finally, Baccarelli et al (Baccarelli et al., 2007) reported no consistent relations 
between air pollution and fibrinogen in 1218 normal subjects from the Lombardia Region, 
Italy. Thus, Even though both fibrinogen (Danesh et al., 2005) and air pollution (Maitre et 
al., 2006) have been independently shown to be positively correlated with cardiovascular 
morbidity and mortality, most epidemiological studies report mainly negative correlations 
between the air pollutants measured and fibrinogen concentrations. Unfortunately enough, 
the direct affect of diesel exhaust exposure on fibrinogen concentration was not reported in 
most of the recent human toxicological studies (Carlsten et al., 2007; Mills et al., 2007; 
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Tornqvist et al., 2007; Lucking et al., 2008). As far as we know the only toxicological report 
was by Bloomberg et al (Blomberg et al., 2005) were no effect was found on fibrinogen 
concentrations. Due to the scarcity of data fibrinogen role as an acute phase reactant 
following diesel exhaust exposure cannot be evaluated. Fibrinogen however, can be viewed 
both as an inflammatory acute phase reactant, as well as a marker for thrombus formation. 
Its consumption, and therefore decrease in concentration following thrombus formation has 
been proposed to increase the diagnostic accuracy of venous thromboembolism (Kucher et 
al., 2003). Lucking et al (Lucking et al., 2008) has established that diesel exhaust inhalation 
increased thrombus formation under low and high shear conditions. The concept of 
fibrinogen consumption due to increased thrombus formation, subsequently leading to a 
decrease in its concentration following exposure to air pollutants, is therefore a subject for 
future toxicological studies.  
Among the possible reasons for the previous conflicting results, in similar studies are: the 
lack of consistent air pollution measurement methodology, the lack of systematic 
examination of the time relationship between air pollution variables and markers of 
inflammation, and the fact that not all studies were controlled for multiple possible 
confounders. These confounders include parameters with known influences on the 
inflammatory response such as age (Larbi et al., 2004), gender (Zeltser et al., 2004), body 
mass index (BMI) and waist circumference (Santos et al., 2005), exercise (Petersen & 
Pedersen, 2005), the presence of hyperlipidemia (Pirro et al., 2004), hypertension (Tsioufis et 
al., 2006), alcohol consumption (Imhof et al., 2001), smoking habits (Yasue et al., 2006), 
glucose concentrations (Kerner et al., 2005), as well as the intake of medications with a 
potential pro- and anti-inflammatory effect (Kushner et al., 2006). In addition there are many 
possible confounders regarding air pollution, mainly meteorological parameters 
(temperature, humidity and precipitants) which may also be related to cardiovascular 
events (Danet et al., 1999) as well as wind speed (Brugge et al., 2007). Finally there are 
seasonal confounders that are closely associated with both cardiovascular morbidity and 
mortality, and air pollution (Nawrot et al., 2006). In order to attain more accurate results we 
accordingly controlled for all these possible confounders. Other than the effect possible 
confounders could have, there were some reports about enhanced sensitivity to the effect of 
air pollution in specific subgroups including asthmatic (Barck et al., 2002), elderly persons 
(Le Tertre et al., 2002), individuals with history of heart failure or arrhythmia (Mann et al., 
2002), females (Chen et al., 2005), naturally higher fibrinogen concentrations (Prescott et al., 
2000), history of cardiorespiratory hospitalization (Zanobetti & Schwartz, 2005) or 
myocardial infarction (von Klot et al., 2005). This enhanced sensitivity was also suggested in 
diabetic, obese and hypertensive individuals who display an association to systemic 
inflammation as evident by CRP, IL-6 and WBC levels (Dubowsky et al., 2006).  
We acknowledge several limitations of the present study. First, we did not account for the 
effect indoor pollutants could have on our study population and their possible influence on 
the results. Second, we did not account for time spent outdoors, which depends on the work 
status and occupation type of each individual in the study. Third, as gender has been known 
to have a significant role in inflammation (Zeltser et al., 2004) and air pollution research 
(Chen et al., 2005) this might have stumped our results. Finally, we note that most previous 
studies have shown a significant decrease in combustion derived air pollutants in distances 
of above 400 meters (Brugge et al., 2007). Thus, and in spite of our multiple adjustments, the 
possibility exist the associations we present are of chance. We therefore encourage repeating 
this analysis in future studies.  
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5. Conclusion  
We have found significant associations between inflammation sensitive biomarkers and 
between combustion derived air pollutants, in individuals residing in a 1000 meter radius 
from a traffic-related air pollution monitoring station, positioned in proximity to heavy 
traffic sites. While our significant results suggest a positive correlation with CRP and a 
negative correlation with fibrinogen and several air pollutants, our results showed be 
cautiously interpreted due to the study limitations.   
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